Diabetes-induced changes in responsiveness of rat bladder and vas deferens to peptides in vitro: Susceptibility to reversal by insulin

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 4, 2002, Pages 334-340

  Cardozo, A H M ^a   Cabrini, D A ^a   Campos, M M ^a   Rae, G A ^a   Huidobro Toro, J P ^a   Calixto, J B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

B1 and B2 agonists; Endothelin; Insulin; Kinins; Rat vas deferens; Streptozotocin diabetic rats; Substance P; Urinary bladder

Indexed keywords

BRADYKININ RECEPTOR AGONIST; BRADYKININ[1-8]; BRADYKININ[8 TYROSINE]; ENDOTHELIN 1; ISOPHANE INSULIN; STREPTOZOCIN; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLADDER; BLADDER CONTRACTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VAS DEFERENS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; INSULIN; MALE; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ; SUBSTANCE P; URINARY BLADDER; VAS DEFERENS;

EID: 0036252414     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-054     Document Type: Conference Paper

References (43)

1. Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats
2. Lipopolysaccharide upregulates bradykinin 1 receptors in the isolated mouse bladder
3. Kinins in pain and inflammation
4. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: Mediation by B1 and B2 receptors
5. Neurokinin mediation of edema and inflammation
6. 2 receptors in streptozotocin-diabetic rats
7. Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats
8. Dysfunction of vascular endothelium in diabetes mellitus
9. Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder
10. Oxidative stress and diabetic vascular complications
11. Diabetic autonomic neuropathy
12. Changes in contractile responses of the urinary bladder to substance P in streptozotocin-induced diabetic rats
13. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases
14. Pain treshold in diabetic rats: Effects of good versus poor diabetic control
15. Transcription factors as targets of cytokine signals
16. Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: Evidence for different structural prerequisites
17. The ability of insulin treatment to reverse or prevent the changes in urinary bladder function caused by streptozotocin-induced diabetes mellitus
18. Effector mechanisms in low-dose streptozotocin-induced diabetes
19. Regulation of the tissue factor gene
20. International Union of Pharmacology nomenclature of endothelin receptors
21. Structural-functional relationships in diabetic nephropathy
22. Tachykinin NK1 receptor subtypes in the rat urinary bladder
23. Pharmacological actions of substance P in the rat vas deferens
24. FR 113680: A novel tripeptide substance P antagonist with NK1 receptor selectivity
25. Endothelin-3 can both facilitate and inhibit transmitter release in the guinea-pig vas deferens
26. The potentiation of ox-LDL induced apoptosis by inhibition of NF-kappaB
27. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue
28. Decrease of bradykinin-induced glomerular contraction in diabetic rat: A new cellular interpretation
29. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors
30. Endothelins in inflammation
31. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B
32. Pharmacology of bradykinin and related kinins
33. Neurokinin receptor subtypes characterized by biological assays
34. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
35. Kininogen and prekallikrein increases in the blood of streptozotocin-diabetic rats are normalized by insulin in vivo and in vitro
36. Increase expression of basement membran collagen in human diabetic retinopathy
37. Characterization of endothelin receptors in streptozotocin-induced diabetic rat vas deferens
38. Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome
39. Free radicals in diabetic endothelial cell dysfunction
40. Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle
41. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus
42. Endothelin modulation of neuroeffector transmission in smooth muscle
43. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells